Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin HIPEC with peritoneal cancer surgery for colorectal or appendiceal peritoneal carcinomatosis
2004-003898-86Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Jul 2005
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in peritoneal carcinomatosis (PC), sponsored by Institut Jules Bordet. Primary endpoint: Early postoperative morbidity and mortality. Started Jul 2005; status: completed.
02
Drugs
oxaliplatin
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on 2004-003898-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003898-86.